ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 281 - 290 of 342
Presenter(s): Jessica E Gormley, PhD, CCC-SLP; Stephanie J Scibilia, MS, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: The COVID-19 pandemic has highlighted a long-standing imperative to address patient-provider communication and inequities in health care settings. This session explores the barriers to effective patient-provider communication and shares potential solutions to these challenges. The speakers discuss the landscape of augmentative and alternative communication (AAC) at health care institutions and highlight the need for collaboration, emergency preparedness, and future-oriented planning.
Presenter(s): Irene brettman, MS, CCC-SLP
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Far-reaching advancements in medicine and technology, coupled with the catalyst of the COVID-19 pandemic, have catapulted telepractice into the forefront of clinical care. This session reviews the rise of telepractice, how it has created a lifeline for patients during the pandemic, and how SLPs can optimize its use across the continuum of care to best serve our patients.
Presenter(s): Alexa J DiPalma, MS, CCC-SLP, CBIS; Hailey Massimino, MS, CCC-SLP; Amanda Koechel, PT, DPT; Colleen M. O'Quinn, OTR/L
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Clinicians across professions-including two speech-language pathologists, an occupational therapist, and a physical therapist-address interdisciplinary care during the COVID-19 pandemic. They discuss challenges clinicians in the long-term acute care setting have faced and review some of the modifications they have made to address these challenges, as well as implications for patient progress and discharge planning.
Presenter(s): Shibani S. Mukerji, MD, PhD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session addresses the question of why patients with COVID-19 have such diverse clinical presentations. The speaker zooms in at the microscopic level to explore the nature and frequency of neurologic sequelae of COVID-19, covering findings observed on neuroimaging and cerebrospinal fluid testing. The session summarizes data from neuropathological studies, discusses new studies on the involvement of the peripheral nervous system, and explores treatment considerations.
Presenter(s): Georgia Cambridge; Tracey Taylor; Wayne Wilson; Wendy Arnott
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a systematic review that aimed to answer the PICO-format clinical research question: For adults with cochlear implants and severe to profound postlingual sensorineural hearing loss, is auditory training effective in improving listening outcomes?
Presenter(s): Stephanie Feller; Akbar Razvi, AuD
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session covers a unique case of bilateral temporal bone fractures: one that spares the otic capsule yet presents with a large sensorineural component. The speaker describes the anatomy and physiology of the temporal bone to provide background information about potential structures that can be damaged in a fracture as well as explain the varying etiologies of temporal bone fractures (TBF). In addition, this session discusses possible outcomes from a TBF in relation to hearing loss and facial nerve function and potential implications for treatment, including cochlear implantation.
Presenter(s): Steven Thomas Kulsar, PhD, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session focuses on the use of in-situ measures and development of patient amplification prescriptions. The importance of in-situ measures is widely overlooked or misunderstood. Dissecting the benefits of this and other built-in manufacturer software features will provide opportunity for significant improvement in fitting outcomes and patient satisfaction over conventional first-fit settings.
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
Presenter(s): Luis F Riquelme, PhD, CCC-SLP, BCS-S
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This course discusses finding a starting place for on-the-job change to address the challenges that COVID-19 presents to patient treatment. The speaker explores how changes related to the pandemic impact your clinical practice, your role in health care, and how you conduct business, as well as actionable next steps you can implement in your workplace.
Presenter(s): Alicia Bazzano, MD, PhD, MPH
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This recorded session from the ASHA Audiology 2022 Online Conference highlights the needs and overall health disparities for people with intellectual and developmental disabilities (IDD). The speaker discusses skills and strategies that audiologists can use to increase their confidence when caring for this population. By identifying and treating hearing-related issues, audiologists can help reduce the communication barriers that people with IDD face, contributing to overall health equity for this population.
<< 25 26 27 28 29 30 31 32 33 34 >>